Letty has been salty about OCC for a while now. IMO it’s obviously good news, but not game changing in and of itself. Market liked it a little bit (up 2% today), seems about right, although I do think the SP is cheap right now after the CR, which should only be a positive for the medium to long term.
Ann: US Nerve Repair Study Design Meets FDA Requirements, page-17
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
-0.015(2.34%) |
Mkt cap ! $149.4M | |||
| Open | High | Low | Value | Volume |
| 64.5¢ | 64.5¢ | 62.0¢ | $124.1K | 195.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12045 | 62.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 20258 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |